1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 HCV Antibody 1.2.3 HCV Viral Load 1.2.4 HCV Genotyping 1.3 Market by Application 1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Diagnostic Centers 1.3.3 Hospitals 1.3.4 Home Use 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hepatitis C Virus (HCV) Antiviral Market Perspective (2017-2028) 2.2 Hepatitis C Virus (HCV) Antiviral Growth Trends by Region 2.2.1 Hepatitis C Virus (HCV) Antiviral Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hepatitis C Virus (HCV) Antiviral Historic Market Size by Region (2017-2022) 2.2.3 Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2023-2028) 2.3 Hepatitis C Virus (HCV) Antiviral Market Dynamics 2.3.1 Hepatitis C Virus (HCV) Antiviral Industry Trends 2.3.2 Hepatitis C Virus (HCV) Antiviral Market Drivers 2.3.3 Hepatitis C Virus (HCV) Antiviral Market Challenges 2.3.4 Hepatitis C Virus (HCV) Antiviral Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue 3.1.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue (2017-2022) 3.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2017-2022) 3.2 Global Hepatitis C Virus (HCV) Antiviral Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Antiviral Revenue 3.4 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio 3.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Antiviral Revenue in 2021 3.5 Hepatitis C Virus (HCV) Antiviral Key Players Head office and Area Served 3.6 Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service 3.7 Date of Enter into Hepatitis C Virus (HCV) Antiviral Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Type 4.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Type (2017-2022) 4.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2023-2028) 5 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Application 5.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Application (2017-2022) 5.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hepatitis C Virus (HCV) Antiviral Market Size (2017-2028) 6.2 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) 6.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size (2017-2028) 7.2 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) 7.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size (2017-2028) 8.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) 8.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size (2017-2028) 9.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) 9.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size (2017-2028) 10.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) 10.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Roche Diagnostics 11.1.1 Roche Diagnostics Company Detail 11.1.2 Roche Diagnostics Business Overview 11.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction 11.1.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.1.5 Roche Diagnostics Recent Development 11.2 Abbott 11.2.1 Abbott Company Detail 11.2.2 Abbott Business Overview 11.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Introduction 11.2.4 Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.2.5 Abbott Recent Development 11.3 Siemens 11.3.1 Siemens Company Detail 11.3.2 Siemens Business Overview 11.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Introduction 11.3.4 Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.3.5 Siemens Recent Development 11.4 Qiagen 11.4.1 Qiagen Company Detail 11.4.2 Qiagen Business Overview 11.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Introduction 11.4.4 Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.4.5 Qiagen Recent Development 11.5 bioMérieux 11.5.1 bioMérieux Company Detail 11.5.2 bioMérieux Business Overview 11.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Introduction 11.5.4 bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.5.5 bioMérieux Recent Development 11.6 Bio-Rad Laboratories 11.6.1 Bio-Rad Laboratories Company Detail 11.6.2 Bio-Rad Laboratories Business Overview 11.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Introduction 11.6.4 Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.6.5 Bio-Rad Laboratories Recent Development 11.7 Meridian Bioscience 11.7.1 Meridian Bioscience Company Detail 11.7.2 Meridian Bioscience Business Overview 11.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Introduction 11.7.4 Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.7.5 Meridian Bioscience Recent Development 11.8 Vista Diagnostics 11.8.1 Vista Diagnostics Company Detail 11.8.2 Vista Diagnostics Business Overview 11.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction 11.8.4 Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.8.5 Vista Diagnostics Recent Development 11.9 Biogate Laboratories 11.9.1 Biogate Laboratories Company Detail 11.9.2 Biogate Laboratories Business Overview 11.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Introduction 11.9.4 Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.9.5 Biogate Laboratories Recent Development 11.10 J.Mitra & Co. Ltd 11.10.1 J.Mitra & Co. Ltd Company Detail 11.10.2 J.Mitra & Co. Ltd Business Overview 11.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Introduction 11.10.4 J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.10.5 J.Mitra & Co. Ltd Recent Development 11.11 Siemens Medical 11.11.1 Siemens Medical Company Detail 11.11.2 Siemens Medical Business Overview 11.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Introduction 11.11.4 Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.11.5 Siemens Medical Recent Development 11.12 General Biologicals 11.12.1 General Biologicals Company Detail 11.12.2 General Biologicals Business Overview 11.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Introduction 11.12.4 General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) 11.12.5 General Biologicals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of HCV Antibody Table 3. Key Players of HCV Viral Load Table 4. Key Players of HCV Genotyping Table 5. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2017-2022) Table 9. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2023-2028) Table 11. Hepatitis C Virus (HCV) Antiviral Market Trends Table 12. Hepatitis C Virus (HCV) Antiviral Market Drivers Table 13. Hepatitis C Virus (HCV) Antiviral Market Challenges Table 14. Hepatitis C Virus (HCV) Antiviral Market Restraints Table 15. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players (2017-2022) Table 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2021) Table 18. Ranking of Global Top Hepatitis C Virus (HCV) Antiviral Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service Table 22. Date of Enter into Hepatitis C Virus (HCV) Antiviral Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2017-2022) Table 26. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2023-2028) Table 28. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2017-2022) Table 30. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2023-2028) Table 32. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2023-2028) & (US$ Million) Table 42. Roche Diagnostics Company Detail Table 43. Roche Diagnostics Business Overview Table 44. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product Table 45. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 46. Roche Diagnostics Recent Development Table 47. Abbott Company Detail Table 48. Abbott Business Overview Table 49. Abbott Hepatitis C Virus (HCV) Antiviral Product Table 50. Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 51. Abbott Recent Development Table 52. Siemens Company Detail Table 53. Siemens Business Overview Table 54. Siemens Hepatitis C Virus (HCV) Antiviral Product Table 55. Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 56. Siemens Recent Development Table 57. Qiagen Company Detail Table 58. Qiagen Business Overview Table 59. Qiagen Hepatitis C Virus (HCV) Antiviral Product Table 60. Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 61. Qiagen Recent Development Table 62. bioMérieux Company Detail Table 63. bioMérieux Business Overview Table 64. bioMérieux Hepatitis C Virus (HCV) Antiviral Product Table 65. bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 66. bioMérieux Recent Development Table 67. Bio-Rad Laboratories Company Detail Table 68. Bio-Rad Laboratories Business Overview Table 69. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product Table 70. Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 71. Bio-Rad Laboratories Recent Development Table 72. Meridian Bioscience Company Detail Table 73. Meridian Bioscience Business Overview Table 74. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product Table 75. Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 76. Meridian Bioscience Recent Development Table 77. Vista Diagnostics Company Detail Table 78. Vista Diagnostics Business Overview Table 79. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Product Table 80. Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 81. Vista Diagnostics Recent Development Table 82. Biogate Laboratories Company Detail Table 83. Biogate Laboratories Business Overview Table 84. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product Table 85. Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 86. Biogate Laboratories Recent Development Table 87. J.Mitra & Co. Ltd Company Detail Table 88. J.Mitra & Co. Ltd Business Overview Table 89. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product Table 90. J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 91. J.Mitra & Co. Ltd Recent Development Table 92. Siemens Medical Company Detail Table 93. Siemens Medical Business Overview Table 94. Siemens Medical Hepatitis C Virus (HCV) AntiviralProduct Table 95. Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 96. Siemens Medical Recent Development Table 97. General Biologicals Company Detail Table 98. General Biologicals Business Overview Table 99. General Biologicals Hepatitis C Virus (HCV) AntiviralProduct Table 100. General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) & (US$ Million) Table 101. General Biologicals Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis C Virus (HCV) Antiviral Market Share by Type: 2021 VS 2028 Figure 2. HCV Antibody Features Figure 3. HCV Viral Load Features Figure 4. HCV Genotyping Features Figure 5. Global Hepatitis C Virus (HCV) Antiviral Market Share by Application in 2021 & 2028 Figure 6. Diagnostic Centers Case Studies Figure 7. Hospitals Case Studies Figure 8. Home Use Case Studies Figure 9. Hepatitis C Virus (HCV) Antiviral Report Years Considered Figure 10. Global Hepatitis C Virus (HCV) Antiviral Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Hepatitis C Virus (HCV) Antiviral Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region: 2021 VS 2028 Figure 13. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players in 2021 Figure 14. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2021 Figure 16. North America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2017-2028) Figure 18. United States Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Country (2017-2028) Figure 22. Germany Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Region (2017-2028) Figure 30. China Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2017-2028) Figure 38. Mexico Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Country (2017-2028) Figure 42. Turkey Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 45. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 46. Siemens Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 47. Qiagen Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 48. bioMérieux Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 50. Meridian Bioscience Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 51. Vista Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 52. Biogate Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 53. J.Mitra & Co. Ltd Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 54. Siemens Medical Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 55. General Biologicals Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Roche Diagnostics Abbott Siemens Qiagen bioMérieux Bio-Rad Laboratories Meridian Bioscience Vista Diagnostics Biogate Laboratories J.Mitra & Co. Ltd Siemens Medical General Biologicals